Conduent (CNDT) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual shareholder meeting scheduled for May 20, 2025, to be held virtually at 10:30 A.M. EDT.
Proxy materials and annual report are available online for review and voting.
Shareholders are encouraged to review all materials and vote electronically or request paper copies by May 9, 2025.
Voting matters and shareholder proposals
Election of five directors: Clifford Skelton, Harsha V. Agadi, Kathy Higgins Victor, Margarita Paláu-Hernández, and Scott Letier.
Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for 2025.
Advisory approval of 2024 compensation for named executive officers.
Board recommends voting FOR all director nominees and FOR Proposals 2 and 3.
Board of directors and corporate governance
Board nominees include a mix of current and new directors, reflecting ongoing governance oversight.
Latest events from Conduent
- 2025 adjusted revenue reached $3.04B with EBITDA margin up to 5.4% amid cost optimization.CNDT
Investor presentation23 Mar 2026 - Margins improved on cost actions despite revenue decline; free cash flow stayed negative.CNDT
Q4 202512 Feb 2026 - Q2 net income rose to $216M on divestitures, with revenue and margins down but leverage reduced.CNDT
Q2 20242 Feb 2026 - Q3 2024 saw $781M adjusted revenue, $123M net income, and major divestitures completed.CNDT
Q3 202416 Jan 2026 - 2024 saw revenue and EBITDA decline but major debt reduction and margin expansion targets for 2025.CNDT
Q4 202423 Dec 2025 - Virtual annual meeting to vote on directors, auditor, and executive pay, with strong ESG focus.CNDT
Proxy Filing1 Dec 2025 - Q2 2025 delivered margin gains and new business growth amid portfolio and AI-driven transformation.CNDT
Q2 202523 Nov 2025 - Adjusted EBITDA margin rose to 4.9% despite revenue decline, driven by cost actions and new business.CNDT
Q1 202521 Nov 2025 - Q3 2025 saw $767M revenue, margin gains, and new signings amid divestitures and funding delays.CNDT
Q3 20257 Nov 2025